A new perspective on B cell triggering: control of the immune response by organizational changes in the lipid bilayer.
D000818:Animals; D000921:Antibody-Producing Cells; D000937:Antigen-Antibody Reactions; D000961:Antilymphocyte Serum; D001402:B-Lymphocytes / Q000276:immunology*; D001666:Binding Sites, Antibody; D002462:Cell Membrane / Q000276:immunology; D003208:Concanavalin A / Q000494:pharmacology; D003601:Cytotoxicity Tests, Immunologic; D000939:Epitopes; D005796:Genes; D006649:Histocompatibility Antigens; D006801:Humans; D007136:Immunoglobulins; D008055:Lipids / Q000276:immunology*; D008213:Lymphocyte Activation; D008264:Macrophages / Q000276:immunology; D008934:Mitogens / Q000494:pharmacology; D008954:Models, Biological; D013601:T-Lymphocytes / Q000276:immunology*
D000961:Antilymphocyte Serum; D000939:Epitopes; D006649:Histocompatibility Antigens; D007136:Immunoglobulins; D008055:Lipids; D008934:Mitogens; D003208:Concanavalin A